175 related articles for article (PubMed ID: 11317529)
1. [The potential of capecitabine (Xeloda) in the treatment of disseminated solid tumors].
Moiseenko VM; Semenova AI; Orlova RV
Vopr Onkol; 2001; 47(1):112-9. PubMed ID: 11317529
[No Abstract] [Full Text] [Related]
2. Oral capecitabine (Xeloda) in cancer treatment.
Doyle DP; Engelking C
Nurse Pract; 2007 Feb; 32(2):18-21. PubMed ID: 17264789
[No Abstract] [Full Text] [Related]
3. Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer.
Wagstaff AJ; Ibbotson T; Goa KL
Drugs; 2003; 63(2):217-36. PubMed ID: 12515569
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine in colorectal, breast, and other solid tumors: novel therapeutic approaches. Selected abstracts from ASCO 2003.
Oncology (Williston Park); 2003 Aug; 17(8 Suppl 8):10-62; quiz 63-4. PubMed ID: 14570064
[No Abstract] [Full Text] [Related]
5. Capecitabine in the management of colorectal cancer.
Maroun JA
Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine: fulfilling the promise of oral chemotherapy.
Hwang JJ; Marshall JL
Expert Opin Pharmacother; 2002 Jun; 3(6):733-43. PubMed ID: 12036413
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine in gastric cancer.
Okines A; Chau I; Cunningham D
Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine: in advanced gastric or oesophagogastric cancer.
Dhillon S; Scott LJ
Drugs; 2007; 67(4):601-10. PubMed ID: 17352519
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.
Cassata A; Procoplo G; Alù M; Ferrari L; Ferrario E; Beretta E; Longarini R; Busto G; De Candis D; Bajetta E
Tumori; 2001; 87(6):364-71. PubMed ID: 11989587
[TBL] [Abstract][Full Text] [Related]
11. X-ACT: an important step on an unfinished journey.
Maughan T
Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
[No Abstract] [Full Text] [Related]
12. Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer.
McGavin JK; Goa KL
Drugs; 2001; 61(15):2309-26. PubMed ID: 11772141
[TBL] [Abstract][Full Text] [Related]
13. An evolving role for oral fluoropyrimidine drugs.
Diasio RB
J Clin Oncol; 2002 Feb; 20(4):894-6. PubMed ID: 11844808
[No Abstract] [Full Text] [Related]
14. Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours.
Sternberg CN; Reichardt P; Holland M
Eur J Oncol Nurs; 2004; 8 Suppl 1():S4-15. PubMed ID: 15341878
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
16. [Oral capecitabine therapy: experience and developments at the Milano Cancer Institute].
Longo F; Mansueto G
Tumori; 2004; 90(1):suppl 17-27. PubMed ID: 15143996
[No Abstract] [Full Text] [Related]
17. Capecitabine: effective oral fluoropyrimidine chemotherapy.
McKendrick J; Coutsouvelis J
Expert Opin Pharmacother; 2005 Jun; 6(7):1231-9. PubMed ID: 15957975
[TBL] [Abstract][Full Text] [Related]
18. Xeloda in colorectal cancer.
Cassidy J
Int J Clin Pract; 2001 Jun; 55(5):326-8. PubMed ID: 11452682
[TBL] [Abstract][Full Text] [Related]
19. Thymidine phosphorylase (TP) activation: convenience through innovation.
Van Cutsem E; Cunningham D; Hoff PM; Maroun J
Oncologist; 2001; 6 Suppl 4():1-2. PubMed ID: 11585967
[No Abstract] [Full Text] [Related]
20. Potential of Xeloda in colorectal cancer and other solid tumors.
Cassidy J
Oncology; 1999 Jul; 57 Suppl 1():27-32. PubMed ID: 10436414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]